Literature DB >> 1471711

Quantitation of tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 in the effusions of ovarian epithelial neoplasms.

W H Kutteh1, C C Kutteh.   

Abstract

OBJECTIVE: Our objective was to determine the presence and quantities of multifunctional cytokines in cyst and ascites fluids obtained from patients with ovarian cancer. STUDY
DESIGN: Cyst and ascites fluids obtained from 35 patients with ovarian epithelial neoplasms were analyzed for the multifunctional cytokines tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6. The fluids were classified on the basis of the pathologic diagnosis of the tumor tissue. Data were evaluated by analysis of variance.
RESULTS: The fluids from patients with papillary forms of adenocarcinoma had high levels of all three cytokines when compared with all other pathologic groups. Interleukin-6 was significantly higher than tumor necrosis factor-alpha or interleukin-1 beta in fluids from all diagnostic categories (p < 0.01). Interleukin-6 levels were significantly higher in fluids from patients with papillary serous cystadenocarcinoma (817 +/- 137 pg/ml) and papillary adenocarcinoma (838 +/- 171 pg/ml) (p < 0.01). Interleukin-1 beta was significantly elevated (p < 0.01) in neoplastic effusions from papillary serous cystadenocarcinomas (53 +/- 8 pg/ml), mucinous cystadenomas (51 +/- 12 pg/ml), and endometrioid carcinomas (54 +/- 18 pg/ml). Tumor necrosis factor-alpha was highest in fluids from patients with papillary adenocarcinoma (46.2 +/- 22.8 pg/ml); however, these levels were not significantly different from the mean quantities of tumor necrosis factor-alpha in other fluids.
CONCLUSIONS: The detection of interleukin-1 beta and interleukin-6 in neoplastic effusions provides possible evidence for a host immune response to ovarian cancer. These multifunctional cytokines have been implicated in growth stimulation and cytotoxicity of ovarian tumor cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1471711     DOI: 10.1016/0002-9378(92)91788-c

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  13 in total

1.  Peptide inhibitors of MK2 show promise for inhibition of abdominal adhesions.

Authors:  Brian C Ward; Sandra Kavalukas; Jamie Brugnano; Adrian Barbul; Alyssa Panitch
Journal:  J Surg Res       Date:  2011-02-23       Impact factor: 2.192

Review 2.  Development of Peritoneal Carcinomatosis in Epithelial Ovarian Cancer: A Review.

Authors:  Juliette O A M van Baal; Cornelis J F van Noorden; Rienk Nieuwland; Koen K Van de Vijver; Auguste Sturk; Willemien J van Driel; Gemma G Kenter; Christianne A R Lok
Journal:  J Histochem Cytochem       Date:  2017-11-22       Impact factor: 2.479

3.  An alternative medium supplement for the culturing and growth of human peritoneal mesothelial cells.

Authors:  M B Michelini-Norris; J Díaz; W S Roberts; D K Blanchard; D P Barton; J Y Djeu
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995 Jul-Aug       Impact factor: 2.416

4.  The homeoprotein DLX4 stimulates NF-κB activation and CD44-mediated tumor-mesothelial cell interactions in ovarian cancer.

Authors:  Dhwani Haria; Bon Quy Trinh; Song Yi Ko; Nicolas Barengo; Jinsong Liu; Honami Naora
Journal:  Am J Pathol       Date:  2015-06-09       Impact factor: 4.307

5.  Transforming growth factor-beta synthesis by human peritoneal mesothelial cells. Induction by interleukin-1.

Authors:  F A Offner; H Feichtinger; S Stadlmann; P Obrist; C Marth; P Klingler; B Grage; M Schmahl; C Knabbe
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

6.  Tumor-associated lymphocytes (TAL) are competent to produce higher levels of cytokines in neoplastic pleural and peritoneal effusions than those found in sera and are able to release into culture higher levels of IL-2 and IL-6 than those released by PBMC.

Authors:  G Mantovani; A Macciò; R Versace; M Pisano; P Lai; S Esu; M Ghiani; D Dessì; E Turnu; M C Santona
Journal:  J Mol Med (Berl)       Date:  1995-08       Impact factor: 4.599

7.  Disruption of the integrity of human peritoneal mesothelium by interleukin-1beta and tumor necrosis factor-alpha.

Authors:  Sylvia Stadlmann; Ruth Raffeiner; Albert Amberger; Raimund Margreiter; Alain Gustave Zeimet; Burkhardt Abendstein; Patrizia Lucia Moser; Gregor Mikuz; Bernd Klosterhalfen; Felix Albert Offner
Journal:  Virchows Arch       Date:  2003-07-26       Impact factor: 4.064

8.  Role of vascular endothelial growth factor in ovarian cancer: inhibition of ascites formation by immunoneutralization.

Authors:  S Mesiano; N Ferrara; R B Jaffe
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

9.  hMSH2 and GTBP expression in advanced stage epithelial ovarian cancer.

Authors:  A Ercoli; G Ferrandina; G Raspaglio; M Marone; N Maggiano; P Del Mastro; P Benedetti Panici; S Mancuso; G Scambia
Journal:  Br J Cancer       Date:  1999-07       Impact factor: 7.640

10.  Higher serum levels of tumour necrosis factor and its soluble receptors are associated with ovarian tumours.

Authors:  Aleksandra Mielczarek-Palacz; Zdzisława Kondera-Anasz; Justyna Sikora
Journal:  Arch Med Sci       Date:  2012-10-30       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.